ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Internal Medicine

Top Internal Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GILBERTO GASTELL M.D.

Internal Medicine

60,021

$4.62M

1537
1399 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 32%

$77
Average prescription price

Avg: $78

JOSEPH CONTI D.O.

Internal Medicine

41,198

$2.48M

1096
948 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 32%

$60
Average prescription price

Avg: $78

SCOTT DORFNER D.O.

Internal Medicine

39,603

$2.98M

1345
908 are 65+

20%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 32%

$75
Average prescription price

Avg: $78

SALEEM MAHMOOD MD

Internal Medicine

32,124

$2.15M

765
506 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 32%

$67
Average prescription price

Avg: $78

DENNIS APONTE MD

Internal Medicine

30,031

$2.36M

813
667 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 32%

$79
Average prescription price

Avg: $78

ALEXANDER SALERNO MD

Internal Medicine

27,614

$3.14M

917
700 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 32%

$114
Average prescription price

Avg: $78

NIK PARIKH MD PA

Internal Medicine

27,098

$2.31M

944
737 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 32%

$85
Average prescription price

Avg: $78

KAMRAN TASHAROFI M.D.

Internal Medicine

26,921

$2.21M

992
808 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 32%

$82
Average prescription price

Avg: $78

FRANK ALARIO M.D.

Internal Medicine

26,712

$2.55M

1656
1378 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 32%

$95
Average prescription price

Avg: $78

AKSHAY PATEL MD

Internal Medicine

24,579

$1.85M

1105
890 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 32%

$75
Average prescription price

Avg: $78

RICHARD JOO MD

Internal Medicine

24,020

$2.25M

777
746 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 32%

$93
Average prescription price

Avg: $78

CARLOS TEJEDA M.D.

Internal Medicine

23,673

$1.75M

617
440 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 32%

$74
Average prescription price

Avg: $78

NICHOLAS PALLADINO MD

Internal Medicine

23,300

$1.32M

768
671 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $78

ARVIND DOSHI M.D.

Internal Medicine

22,329

$1.34M

560
519 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 32%

$60
Average prescription price

Avg: $78

BORIS LIVSHITS M.D.

Internal Medicine

22,109

$1.76M

440
415 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 32%

$79
Average prescription price

Avg: $78

JAVED YOUSAF M.D.

Internal Medicine

21,966

$1.26M

620
586 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $78

SUBHASH MEHTA MD

Internal Medicine

21,700

$1.61M

618
440 are 65+

20%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 32%

$74
Average prescription price

Avg: $78

JAY VIDA DO

Internal Medicine

20,800

$1.36M

873
812 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 32%

$65
Average prescription price

Avg: $78

ROBERT LIPSHUTZ DO

Internal Medicine

20,525

$1.14M

710
641 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 32%

$56
Average prescription price

Avg: $78

LUBNA AHMED MD

Internal Medicine

20,445

$1.25M

484
440 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 32%

$61
Average prescription price

Avg: $78

MOHAMMAD CHAUDHRY M.D.

Internal Medicine

20,329

$1.86M

1044
875 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 32%

$92
Average prescription price

Avg: $78

LISA RINK D.O.

Internal Medicine

20,298

$1.22M

687
560 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 32%

$60
Average prescription price

Avg: $78

JULIO HUBERT

Internal Medicine

19,754

$1.28M

340
264 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 32%

$65
Average prescription price

Avg: $78

ROMEL ARJONA M.D

Internal Medicine

19,647

$1.57M

681
515 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 32%

$80
Average prescription price

Avg: $78

KUMAR RAMDAS M.D.

Internal Medicine

19,182

$1.68M

777
562 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 32%

$87
Average prescription price

Avg: $78

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank